UGM & Conference in Europe

Integrating novel tools into development workflow of biologics: nanoDSF and MST for Discovery, Development and QC

Alexey Rak
Head of Bio Structure and Biophysics, Integrated Drug Discovery, , Sanofi R&D
(THURSDAY, May 18 - Scientific Presentations, 14:00-14:30)

Biophysical approaches are routinely used to assess biologics activities, stability and quality. Modern drug discovery operations require characterization of biomolecular interactions to be both time- and cost-effective as well as to be highly precise and reproducible. Here we report applications of two novel predictive, precise, low protein consuming and high throughput methods: nano-Differential Scanning Fluorimetry (nanoDSF ) and MicroScale Thermophoresis (MST) that we apply in our biologics discovery and characterization operations. The examples of the demonstrated effectiveness of the nanoDSF and MST will be presented and discussed.

The audience will gain further insight into:

  • new approaches in biologics discovery, development and QC
  • advantages applying novel MST and nanoDSF methods
  • efficiency of the newly developed technologies and applications for biologics